← Back to Search

Behavioral Intervention

E-cigarette for Smoking Cessation

N/A
Waitlist Available
Led By Darla Kendzor, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks post-enrollment/4 weeks post-quit/switch date
Awards & highlights

Study Summary

This trial will study how well e-cigarettes work to help homeless adults quit smoking cigarettes, compared to just e-cigarettes or e-cigarettes with financial incentives.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks post-enrollment/4 weeks post-quit/switch date
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks post-enrollment/4 weeks post-quit/switch date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cigarette Smoking Cessation
Switching to e-Cigarettes
Secondary outcome measures
Financial Incentives Earned
Loss of e-cigarette devices

Trial Design

2Treatment groups
Experimental Treatment
Group I: Financial Incentives + E-cigaretteExperimental Treatment1 Intervention
Participants will be asked to completely switch from cigarettes to e-cigarettes, and they will receive an e-cigarette device and pods during the first 4 weeks following a scheduled switch date. Participants will also receive weekly financial incentives for biochemically-verified cigarette abstinence during the first 4 weeks following the switch date.
Group II: E-CiagretteExperimental Treatment1 Intervention
Participants will be asked to completely switch from cigarettes to e-cigarettes. They will receive an e-cigarette device and pods during the first 4 weeks following a scheduled switch date.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
E-cigarette
2017
Completed Phase 1
~830
Financial incentives + E-cigarette
2022
N/A
~60

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,550 Total Patients Enrolled
Darla Kendzor, PhDPrincipal InvestigatorUniversity of Oklahoma
4 Previous Clinical Trials
84 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this study still open?

"As per clinicaltrials.gov, this medicinal experiment is no longer enrolling participants, having been posted on the 14th of September 2022 and most recently updated on the 3rd of October 2022. Nonetheless, there are presently 143 other trials that are actively seeking patients."

Answered by AI

Is the age threshold for enrolment in this clinical trial eighteen years or older?

"This clinical trial calls for participants aged between 18 and 100. In contrast, separate trials have been organized to accommodate minors (under the age of 18) and elderly patients (over 65). Specifically, there are 5 such studies directed at children and 131 that cater to older adults."

Answered by AI

Is enrollment open for this medical research project?

"This clinical study seeks 60 adults, aged 18-100 with current smoking habits who possess at least sixth grade English literacy. Additionally, applicants must have an expired carbon monoxide level greater than 8 ppm and a daily cigarette consumption of 5 or more. Participants should expect to attend six weekly visits spanning five weeks and be motivated to quit smoking soon while also abstaining from marijuana and e-cigarette use in the past month. Furthermore, those enrolled may not currently be pregnant or breastfeeding nor planning pregnancy during the trial period."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
Homeless Alliance
What portion of applicants met pre-screening criteria?
Met criteria
~23 spots leftby Apr 2025